Roman Kischel to Speak at Immunotherapeutics & Immunomonitoring Jan 2014, CA

San Diego, CA, October 11, 2013 --(PR.com)-- Roman Kischel at Amgen, will give a presentation on “Immunotherapy of Cancer with BiTE® Antibodies” at the 6th Immunotherapeutics & Immunomonitoring Conference to be held in San Diego, CA on January 29-31, 2014 by GTC.

Roman Kischel is Principal Scientist at Amgen Research (Munich) GmbH, Germany. Roman leads a group developing novel BiTE antibodies specific for different tumor target antigens. Roman has been with Amgen and before the acquisition by Amgen with Micromet for 12 years, working mainly on design and characterization of BiTE antibodies. Previously Roman worked at the Institut für Immunologie at the Ludwig-Maximilians-Universität in Munich.

Network with leading experts from the scientific and clinical arenas as well as investigators in industry to discuss novel findings and developments in immunological assays and procedures. Learn about recent advances in immunotherapy, as they relate to various modalities, specific cancers, cell subsets, and animal models. Discuss potential clinical feasibility and commercial potential of the newest data obtained from leading biomedical research laboratories.

This conference is part of the Novel Immunotherapeutics Summit 2014, which includes three additional parallel conferences shown below:

12th Cytokines & Inflammation
2nd Immunogenicity & Immunotoxicity
Inaugural Innate Immunity

For more information, please visit www.gtcbio.com